By proceeding, you agree to our Terms of Use and Privacy Policy.
With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater.
Learn about patient-specific IPSCS as a human preclinical model of pulmonary fibrosis and harnessing preclinical models to support translatability.
Discover paths on how to leverage precision-cut lung slices for IPF research and how to use biomarkers efficiently in IPF clinical trials.
Connect with leaders and experts like Andrew Haak, Bertil Lindmark and Brian Windsor from companies like Mayo Clinic and Galecto Biotech.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Nordic Bioscience is the leading expert in extracellular matrix (ECM) research with 25+ years of experience in biomarker development, pre-clinical and clinical research.
Vitalograph is a global leader in respiratory diagnostics. We manufacture and supply high quality spirometers and medical devices which aid the detection, diagnosis and management of respiratory conditions.
IPS Therapeutique (IPST) is a Contract Research Organization dedicated to the preclinical evaluation of the efficacy and safety of new drugs using validated and highly predictive models.
Owlstone Medical is on a mission is to save 100,000 lives and $1.5bn in healthcare costs. We have developed the Breath Biopsy platform, using breath analysis for precision medicine and the early detection of disease.
Rules-Based Medicine (RBM), a Q2 Solutions Company, is the world’s leading multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and a novel whole blood immunophenotyping device
Xylyx Bio's platform technology of tissue-specific ECM substrates, clinically relevant data packages, and compound testing services increases predictiveness and informs better decision making in drug discovery, saving precious time and money in the q
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.